| [1] |
Massaad MJ, Ramesh N, Geha RS. Wiskott-Aldrich syndrome: a comprehensive review[J]. Ann N Y Acad Sci, 2013, 1285：26–43.
|
| [2] |
Buchbinder D, Nugent DJ, Fillipovich AH. Wiskott-Aldrich syndrome：diagnosis, current management, and emerging treatments [J]. Appl Clin Genet, 2014, 7：55–66.
|
| [3] |
Bosticardo M, Marangoni F, Aiuti A, et al. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome [J]. Blood, 2009, 113(25)：6288–6299.
|
| [4] |
Albert MH, Notarangelo LD, Ochs HD. Clinical spectrum, pathophysiology and treatment of the Wiskott-Aldrich syndrome[J]. Curr Opin Hematol, 2011, 18(1)：42–48.
|
| [5] |
Thrasher AJ, Burns SO. WASP: a key immunological multitasker[J]. Nat Rev Immunol, 2010，10(3)：182–192.
|
| [6] |
Blundell MP, Worth A, Bouma G, et al. The Wiskott-Aldrich syndrome: the actin cytoskeleton and immune cell function[J]. Dis Marker, 2010，29(3-4)：157–175.
|
| [7] |
Liu DW，Zhang ZY, Zhao Q，et al. Wiskott-Aldrich syndrome/X-linked thrombocytopenia in China: clinical characteristics and genotype-phenotype correlation[J/OL]. Pediatr Blood Cancer，2015，62[2015-04-30]．published online ahead of print April 30，2015]
URL
|
| [8] |
Ochs HD. Mutations of the Wiskott-Aldrich syndrome protein affect protein expression and dictate the clinical phenotypes[J]. Immunol Res, 2009, 44(12-3)：84–88.
|
| [9] |
Moratto D, Giliani S, Notarangelo LD, et al. The Wiskott-Aldrich syndrome: from genotype-phenotype correlation to treatment[J]. Expert Rev Clin Immunol, 2007, 3(5)：813–824.
|
| [10] |
Jin Y, Mazza C, Christie JR, et al. Mutations of the Wiskott-Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlations[J]. Blood, 2004, 104(13)：4010–4019.
|
| [11] |
Albert MH, Bittner TC, Nonoyama S, et al. X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options[J]. Blood, 2010, 115(16)：3231–3238.
|
| [12] |
赵琴，蒋利萍，于洁，等. 24例Wiskott- Aldrich综合征患儿基因型与临床表现型的关系[J]. 第三军医大学学报，2011，339(13)：1404–1407.
|
| [13] |
Pai SY, Notarangelo LD. Hematopoietic cell transplantation for wiskott-aldrich syndrome: advances in biology and future directions for treatment[J]. Immunol Allergy Clin North Am, 2010；30(2)：179–194.
|
| [14] |
Lee WI, Huang JL, Jaing TH, et al. Clinical aspects and genetic analysis of Taiwanese patients with Wiskott-Aldrich syndrome protein mutation: the first identification of X-linked thrombocytopenia in the Chinese with novel mutations[J]. J Clin Immunol, 2010, 30(4): 593–601.
|
| [15] |
Ochs HD, Filipovich AG, Veys P, et al.Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment[J]．Biol Blood Marrow Transplant，2009，15(1 Suppl)：84–90.
|
| [16] |
Wada T, Itoh M, Maeba H, et al. Intermittent X-linked thrombocytopenia with a novel WAS gene mutation[J]. Pediatr Blood Cancer，2014, 61(4)：746–748.
|
| [17] |
Balduini CL, Pecci A, Noris P. Diagnosis and management of inherited thrombocytopenias[J]. Semin Thromb Hemost，2013；39(2)：161–171.
|
| [18] |
Pecci A, Balduini CL. Lessons in platelet production from inherited thrombocytopenia[J]. Br J Haematol, 2014, 165(2)：179–192.
|
| [19] |
Noris P, Biino G, Pecci A, et al. Platelet diameters in inherited thrombocytopenia：analysis of 376 patients with all known disorders[J]. Blood, 2014, 124(6)：e4–e10.
|
| [20] |
Noris P, Klersy C, Gresele P, et al. Platelet size for distinguishing between inherited thrombocytopenia and immune thrombocytopenia[J]. Br J Haematol, 2013，162(1)：112–119.
|